Shares of Aurora Cannabis Inc. ACB rose 1.21% to $5.86 Thursday, on what proved to be an all-around dismal trading session ...

The year is a more than a month old, but Aurora Cannabis (NASDAQ: ACB) is already one of the hottest stocks to own in 2025.

Shares of Aurora Cannabis Inc. ACB slipped 4.28% to $6.04 Tuesday, on what proved to be an all-around positive trading ...

In combination with improved efficiency in the company's manufacturing operations and recent cost reduction initiatives, Aurora's medical cannabis gross margin increased by 600 basis points ...

Shares of Aurora Cannabis (NASDAQ:ACB) added ~27% in the premarket on Wednesday after the Canadian marijuana producer reported better-than-expected revenue for Q3 fiscal 2025, thanks mainly to its ...

Dario Sabaghi covers the cannabis industry with a focus on Europe. Canadian company Aurora Cannabis has announced the launch of its first German-cultivated medical cannabis product amid the easing ...

Canaccord raised the firm’s price target on Aurora Cannabis (ACB) to C$12.50 from C$10 and keeps a Buy rating on the shares.Maximize Your ...

The term of the agreement is for three years with an option to extend and an estimated value of $27 million. EDMONTON — Aurora Cannabis signs a supply agreement with SNDL, a Canadian licensed ...

Medical cannabis company Aurora Cannabis (ACB) has surprised markets with a record-breaking third quarter, sending its shares ...

"Aurora is proud to deliver to the rapidly growing German market our first domestically produced medical cannabis product – a significant step forward since Germany's move to decriminalize ...

EDMONTON, AB, February 6, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis company, is pleased ...

Aurora Cannabis reported 37% revenue growth in its most recent quarter. The company also posted a profit. The international medical cannabis market has played a key role in its recent rapid growth.